MYND Lifesciencs Inc
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.
MYND Lifesciencs Inc (MYNDF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of July 2024: 0.000x
Based on the latest financial reports, MYND Lifesciencs Inc (MYNDF) has a cash flow conversion efficiency ratio of 0.000x as of July 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.25K) by net assets ($-5.99 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
MYND Lifesciencs Inc - Cash Flow Conversion Efficiency Trend (2021–2023)
This chart illustrates how MYND Lifesciencs Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
MYND Lifesciencs Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MYND Lifesciencs Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fridenson
TA:FRDN
|
0.000x |
|
JUNIPER NETWORKS
BE:JNP
|
0.041x |
|
Procaps Group S.A. Warrants
NASDAQ:PROCW
|
1.232x |
|
Maverix Metals Inc
STU:7781
|
0.029x |
|
TOKYO GAS
BE:TOG
|
N/A |
|
Hankuk Carbon Co. Ltd.
KQ:017960
|
N/A |
|
SANDVIK - Dusseldorf Stock Exchang
DU:SVKB
|
0.075x |
|
KAO (KAO.SG)
STU:KAO
|
0.062x |
Annual Cash Flow Conversion Efficiency for MYND Lifesciencs Inc (2021–2023)
The table below shows the annual cash flow conversion efficiency of MYND Lifesciencs Inc from 2021 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-10-31 | $-4.98 Million | $-198.26K | 0.040x | -92.27% |
| 2022-10-31 | $-3.53 Million | $-1.82 Million | 0.515x | -98.83% |
| 2021-10-31 | $-67.97K | $-2.98 Million | 43.878x | -- |